Serum amyloid A inhibits osteoclast differentiation to maintain macrophage function

Area of Science:

• Immunology
• Cell Biology
• Rheumatology

Background:

• Serum amyloid A (SAA) is an acute phase protein linked to inflammatory conditions like arthritis.
• Elevated SAA levels correlate with inflammatory arthritis progression, suggesting a role in bone metabolism.
• The precise mechanisms by which SAA influences osteoclast differentiation remain unclear.

Purpose of the Study:

• To investigate the effects of SAA on osteoclast differentiation and function.
• To elucidate the molecular pathways involved in SAA-mediated regulation of osteoclastogenesis.

Main Methods:

• Bone marrow-derived macrophages were stimulated with SAA in the presence of M-CSF and RANKL.
• Osteoclast differentiation and bone resorption activity were assessed.
• The role of Toll-like receptor 2 (TLR2) was examined using TLR2-deficient mice.
• Expression levels of key transcription factors (c-Fos, NFATc1, IRF-8) and proinflammatory cytokines were analyzed.

Main Results:

• SAA significantly inhibited osteoclast differentiation and bone-resorption activity.
• The inhibitory effect of SAA was dependent on TLR2 activation.
• SAA suppressed the expression of c-Fos and NFATc1 while preventing IRF-8 downregulation.
• SAA enhanced macrophage endocytic capacity and the induction of IL-6, IL-1β, and TNF-α.

Conclusions:

• SAA inhibits osteoclast differentiation and function, likely via TLR2 signaling.
• SAA may play a protective role in inflammatory arthritis by limiting bone destruction.
• SAA maintains macrophage functions crucial for host defense during inflammation.